CCL5 and atherosclerosis: Met-RANTES has been shown to reduce atherosclerosis in Ldlr-deficient mice or to reverse electrocardiac dysfunction (i.e., bradycardia, prolonged PR, and QTc interval) in chronic Trypanosoma cruzi infection [110,111].